VeriSIM CEO Jo Varshney Selected Finalist for 2023 Stevie® Awards for Women in Business
"Most Innovative Woman of the Year—Healthcare" will be unveiled on November 10
SAN FRANCISCO, Sept. 25, 2023 /PRNewswire/ -- Jo Varshney, Founder and CEO of VeriSIM Life—developers of the world's first "credit score" for de-risking drug development— was announced as a finalist in the "Most Innovative Woman of the Year—Healthcare" category of the 20th annual Stevie® Awards for Women in Business. The Stevie Awards honor the world's top women entrepreneurs, executives, employees, and the organizations they run.
Varshney is among seven finalists for "Most Innovative Woman of the Year— Healthcare" and is in elite company alongside healthcare leaders like Axis Research & Technologies COO Jill Goodwin, Biohaven SVP for Clinical Operations Kim Gentile, Recursion COO Tina Larson, Elevance Health CTO Geeta Wilson, SUN HOPE President Masami Toda, and Dr. Lisa Langer, Ph.D. This year's Stevie Awards for Women in Business received more than 1,600 nominations by organizations and individuals for consideration across 100 categories.
"It is an honor to be selected as a finalist for the 2023 Stevie Awards alongside so many outstanding professionals and executives who have dedicated their careers to innovation in the healthcare industry, which is at a critical inflexion point," said Varshney. "I am proud to be part of a new solution to address the cost and time it takes to bring drugs to market, which has doubled every 10 years, resulting in only 40 new drug approvals annually, while 300 million patients with unmet diseases await new therapies."
Varshney was nominated for the Healthcare Stevie Award for her leadership in the novel use of artificial intelligence and machine learning techniques to improve the value of drug candidate intellectual property early in the developmentlifecycle. VeriSIM Life's technology uses AI and ML to derive a drug development "credit score", which radically decreases the risk of errors and failure in the drug research process, improves clinical trials and early patient application success rates, and ultimately decreases time-to-market for novel therapeutics.
"I am continually grateful for the passionate and talented individuals who I get to call my team at VeriSIM Life for driving our innovations. This award is a testament, not only to contributions of women in technology, but also to the broader diversity of our team, which should inspire future leaders with unique and divergent backgrounds."
Created in 2002, the Stevie Awards are a series of eight awards programs that elevate and publicly recognize the achievements and positive contributions of organizations and professionals around the world. Gold, Silver, and Bronze award winners will be announced during the Stevie Awards gala on Friday, November 10 at the Marriott Marquis Hotel in New York City.
About VeriSIM Life
About the Stevie® Awards
View original content to download multimedia:https://www.prnewswire.com/news-releases/verisim-ceo-jo-varshney-selected-finalist-for-2023-stevie-awards-for-women-in-business-301937489.html
SOURCE VeriSIM Life